Theravance Biopharma Inc TBPH 深 沪
已收盘 02-06 16:00:00 美东时间
20.48
+0.900
+4.60%
华盛通- 最 高20.49
- 今 开19.57
- 成交量 77.84万股
- 最 低 19.00
- 昨 收 19.58
- 总市值 10.38亿
- 52周最高 21.03
- 市盈率 静 --
- 换手率 1.54%
- 52周最低 7.90
- 委 比 -89.53%
- 总股本 5067.24万
- 历史最高 43.44
- 量 比 2.17
- 振 幅 7.61%
- 历史最低 6.10
- 每 手 1
- 风险率 3.73%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅213.87%！Wave Life Sciences获Canaccord Genuity升目标价至43美元，维持"买入"评级
今日重点评级关注：Canaccord Genuity：维持Wave Life Sciences Ltd."买入"评级，目标价从40美元升至43美元；花旗：维持Palantir Technologies"买入"评级，目标价从235美元升至260美元
02-04 12:15
BTIG Reiterates Buy on Theravance Biopharma, Maintains $40 Price Target
BTIG analyst Julian Harrison reiterates Theravance Biopharma (NASDAQ:TBPH) with a Buy and maintains $40 price target.
02-03 20:11
Jefferson Capital, Mobix Labs And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures falling 0.2% o...
01-06 21:12
Theravance Biopharma Hosts Key Opinion Leader Event
The latest announcement is out from Theravance Biopharma ( ($TBPH) ). On Decemb...
2025-12-08 19:56
美股大行评级 | 美鹰服饰、CrowdStrike、迈威尔科技获多家机构上调目标价；ACHC、GitLab、Okta遭多家机构下调目标价
今日重点评级关注：Guggenheim：维持Cybin Inc. Common Shares"买入"评级，目标价从39美元升至48美元；HC Wainwright & Co.：维持Capricor Therapeutics"买入"评级，目标价从24美元升至60美元
2025-12-04 09:38
Oppenheimer Initiates Coverage On Theravance Biopharma with Outperform Rating, Announces Price Target of $27
Oppenheimer analyst Trevor Allred initiates coverage on Theravance Biopharma (NASDAQ:TBPH) with a Outperform rating and announces Price Target of $27.
2025-12-04 00:31
Broadcom To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a comple...
2025-11-26 21:09
BTIG Maintains Buy on Theravance Biopharma, Raises Price Target to $40
BTIG analyst Julian Harrison maintains Theravance Biopharma (NASDAQ:TBPH) with a Buy and raises the price target from $25 to $40.
2025-11-26 20:11
美股牛股 | ENGN隔夜大涨近47%！膀胱癌基因疗法试验数据表现积极；二手奢侈品在线交易平台REAL涨超38%
ENGN隔夜大涨近47%！膀胱癌基因疗法试验数据表现积极；二手奢侈品在线交易平台REAL涨超38%，Q3业绩超预期及上调财年销售指引>>
2025-11-12 18:55
美股大行评级 | CoreWeave、Monday遭美银、小摩等多家大行下调目标价；中金首予Nebius "跑赢大市"评级，目标价143美元
今日重点评级关注：Piper Sandler：维持MeiraGTx Hldgs"超配"评级，目标价从28美元升至30美元；RBC Capital：维持4D Molecular Therapeutics"跑赢大市"评级，目标价从26美元升至32美元
2025-11-12 11:43
